Skip to main content

Pfizer Extends KnowledgeScan Software Agreement With BioWisdom

NEW YORK (GenomeWeb News) — BioWisdom will again use its KnowledgeScan software to help Pfizer in a drug-discovery project, BioWisdom said yesterday.
 
Pfizer plans to use the software to “assess the market opportunity, potential strategy, and clinical trial design” for an undisclosed class of compounds, BioWisdom said.
 
Financial terms of the agreement were not released.
 
A similar agreement was penned in June 2006. 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.